The overall cost for a patient treated with a 5-day course of 40 capsules of the generic drug, to be sold under brand name 'Molflu', will come up to 1,400 rupees ($18.77). In comparison, the treatment with Merck's pill in the United States costs $700.
ВладимирВладимирович έγραψε:Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pillThe overall cost for a patient treated with a 5-day course of 40 capsules of the generic drug, to be sold under brand name 'Molflu', will come up to 1,400 rupees ($18.77). In comparison, the treatment with Merck's pill in the United States costs $700.
Για να δουμε, ποια χάπια θα παρει η κυβερνησαρα των αριστων;
Με το τζενερικ δύσκολα να πεφτει καλη μίζα
Λαχουρένιος έγραψε:ВладимирВладимирович έγραψε:Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
Για να δουμε, ποια χάπια θα παρει η κυβερνησαρα των αριστων;
Με το τζενερικ δύσκολα να πεφτει καλη μίζα
40 χαπια? Ψεκασμενοι χαπακηδες. Τυφλα να χουν οι ρειβαδες.
Molnupiravir: long-term safety questions linger as approvals approach
https://www.pharmaceutical-technology.c ... -approach/
Merck’s COVID pill loses its lustre: what that means for the pandemic
Molnupiravir was initially heralded by public-health officials as a game-changer for COVID-19, but full clinical-trial data showed lower-than-expected efficacy.
https://www.nature.com/articles/d41586-021-03667-0
Merck’s COVID-19 pill and the ‘unknown risk’ of DNA mutation
In a University of North Carolina study, the drug induced low levels of mutations in hamster cells, leading some experts to suggest the drug be limited to patients at high risk.
https://www.inquirer.com/health/coronav ... 11014.html